SCHEMBL4915922

SCHEMBL4915922

CC(CO)OC(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.70
CD274 Q9NZQ7 1/20 0.70
SLC1A5 Q15758 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
KDM4E B2RXH2 1/20 0.49
EGFR P00533 1/20 0.48
MAPT P10636 4/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
UTS2R Q9UKP6 1/20 0.47
SCN1A P35498 2/20 0.47
SCN2A Q99250 2/20 0.47
SCN3A Q9NY46 2/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
POLB P06746 1/20 0.47
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1926470 0.90 LMNA (0.55) PDCD1CD274SMN1; SMN2SCN1ASCN2A
SCHEMBL525077 0.90 LMNA (0.55) PDCD1CD274SMN1; SMN2SCN1ASCN2A
SCHEMBL570078 0.88 PDCD1 (0.72) PDCD1CD274SLC1A5SMN1; SMN2KDM4E
SCHEMBL7615892 0.88 CYP4F2 (0.55) PDCD1CD274KDM4EMAPTL3MBTL1
SCHEMBL25615625 0.87 PDCD1 (0.70) PDCD1CD274SLC1A5SMN1; SMN2KDM4E
SCHEMBL12724883 0.85 PDCD1 (0.68) PDCD1CD274SLC1A5SMN1; SMN2KDM4E
SCHEMBL855278 0.84 MAPT (0.51) PDCD1CD274SMN1; SMN2MAPTSCN1A
SCHEMBL296543 0.82 PDCD1 (1.00) PDCD1CD274SLC1A5SMN1; SMN2KDM4E
SCHEMBL20682164 0.81 PDCD1 (0.57) PDCD1CD274SLC1A5SMN1; SMN2KDM4E
SCHEMBL2838336 0.81 CA12 (0.67) PDCD1CD274SMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306145-A1 Preparation Of Ginkgolide And F-Seco-Ginkgolide Lactols THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2008-12-11 US disclosed
WO-2006083366-A2 PREPARATION OF GINKGOLIDE AND F-SECO-GINKGOLIDE LACTOLS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2006-08-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306145-A1 Preparation Of Ginkgolide And F-Seco-Ginkgolide Lactols GID4, GALK1, GGPS1 PDCD1 3150/4885CD274 2886/4885SLC1A5 3750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.